Viking Therapeutics, Inc. (VKTX) Debt Components
- 2018-03-31: Convertible Notes Payable, CurrentUSD $3.72M; Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Interest Rate During Periodpure (m).
- 2017-12-31: Convertible Notes Payable, CurrentUSD $3.45M; Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Interest Rate During Periodpure (m).
- 2017-09-30: Convertible Notes Payable, CurrentUSD $3.18M; Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Interest Rate During Periodpure (m).
- 2017-06-30: Convertible Notes Payable, CurrentUSD $3.05M; Debt Instrument, Interest Rate, Stated Percentagepure (m); Debt Instrument, Interest Rate During Periodpure (m).
Viking Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Interest Rate During Period pure |
|---|---|---|---|
| 2018-03-31 | $3.72M | (m) | (m) |
| 2017-12-31 | $3.45M | (m) | (m) |
| 2017-09-30 | $3.18M | (m) | (m) |
| 2017-06-30 | $3.05M | (m) | (m) |
| 2016-12-31 | (m) | (m) | 12 month · 5.00% |
| 2016-12-31 | $3.27M | (m) | (m) |
| 2016-12-31 | (m) | 5.00% | (m) |
| 2016-09-30 | (m) | (m) | 9 month · 2.50% |
| 2016-09-30 | $2.83M | 2.50% | (m) |
| 2016-06-30 | (m) | (m) | 6 month · 2.50% |
| 2016-06-30 | $2.38M | 2.50% | (m) |
| 2016-03-31 | (m) | 2.50% | (m) |
| 2016-01-22 | (m) | (m) | 2.50% |
| 2016-01-22 | (m) | 2.50% | (m) |
| 2015-12-31 | (m) | (m) | 12 month · 5.00% |
| 2015-12-31 | (m) | 5.00% | (m) |
| 2015-09-30 | $1.91M | (m) | (m) |
| 2015-06-30 | $1.67M | (m) | (m) |
| 2015-03-31 | (m) | 5.00% | (m) |
| 2015-03-31 | $310.35K | (m) | (m) |
| 2014-12-31 | $304.27K | 5.00% | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |